MedTrace Logo

A Two-Week Crossover Dispensing Evaluation Of Orion Daily Wear Soft Contact Lens

NCT04585646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2022-05-10

Study results available
· View outcomes & findings →

Summary

The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear.

Conditions

  • Myopia

Interventions

DEVICE

Orion daily disposable contact lens

Subjects will be randomized to wear Orion lens for 2 weeks.

DEVICE

Gemini daily disposable contact lens

Subjects will be randomized to wear Gemini lens for 2 weeks.

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Pete S Kollbaum · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2020-11-30
Completion
2020-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04585646 on ClinicalTrials.gov